Compare OBIO & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBIO | OIA |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 290.8M |
| IPO Year | N/A | N/A |
| Metric | OBIO | OIA |
|---|---|---|
| Price | $4.42 | $6.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 299.6K | 97.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,818,000.00 | N/A |
| Revenue This Year | $36.43 | N/A |
| Revenue Next Year | $2.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.46 | N/A |
| 52 Week Low | $2.20 | $4.93 |
| 52 Week High | $6.30 | $6.72 |
| Indicator | OBIO | OIA |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 57.58 |
| Support Level | $4.19 | $6.06 |
| Resistance Level | $4.69 | $6.20 |
| Average True Range (ATR) | 0.30 | 0.07 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 24.51 | 58.62 |
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.